As international opportunities for Canadian cannabis companies continue to expand in various countries, a research-focused company of cannabinoid-based therapies has officially announced its plans to enter the Colombian market.

On Monday (April 9) Scythian Biosciences (TSXV:SCYB; OTCQB:SCCYF), unveiled its intentions to acquire MMJ Colombia Partners, a company embedded in the medical cannabis market for Colombia currently expanding that footprint.


Following completion of the deal, Scythian will be the sole shareholder of MMJ Colombia and MMJ’s most recent acquisition in process. MMJ Colombia is taking steps to acquire 90 percent of the issued and outstanding shares of Colombian company ColCanna.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

The terms of this acquisition make it dependant on the completion of MMJ Colombia’s acquisition of ColCanna and to fully acquire Colombian licenses for the cultivation, production, research, and export of medical cannabis CBD and THC extracts.

“With a climate that allows four harvests a year, we can now expand our production, research and retail of the highest quality cannabis products in Colombia and the world,” Jonathan Gilbert, Scythian CEO said.

As part of the acquisition, Scythian also detailed a variety of considerations, including an advance of US$1.2 million of the purchase price in cash, once receiving ColCanna’s final licenses. According to its announcement, Scythian will also:

Issue on the closing date CDN$32,000,000 of common shares in the capital of Scythian (the “Common Shares”) at an issue price equal to the volume weighted average price of the Common Shares over the 20 trading days prior to the closing date of the Acquisition, provided that no less than 1,570,000 Common Shares will be issued as share consideration.

Scythian will also issue US$5 million of non-interest bearing, unsecured promissory notes due at specific dates all throughout 2018 and into next year.

As previously reported by the Investing News Network (INN) the Colombian cannabis market has provided an option of growth for companies raising funds through the Canadian stock exchanges.

Alvaro Torres, president, and CEO of Khiron Life Sciences–a company seeking to offer its stock in Canada–told INN the Colombian market is too attractive for other producers to let go.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

“In the end, we have to look for bigger markets and all the LPs (licensed producer) are looking at the way that they can continue opening up their well-known strategies and well-known cultivation activities into a market that is just opening up, which is Colombia,” Torres said.

“As more countries legalize cannabis for medicinal use, Colombia is positioned to become a dominant supplier to these new countries as they ramp up their own domestic production capacity,” Ryan Douglas a cannabis growth consultant told Marijuana Business Daily.

In an interview with INN, Neil Closner, CEO of MedReleaf (TSX:LEAF) previously said he believes the international market for medical cannabis is the biggest option available for medically focused companies.

“[T]here are a lot of countries that are advancing legislation to legalize medical cannabis… and many of those countries are more medically focused and medical rigorous than even Canada is today,” he said.

Closner added the countries he references already have cannabis covered for medical purposes as part of their insurance coverage.

Investor takeaway

It will be key for Scythian shareholders to watch on the development of ColCanna’s acquisition by MMJ Colombia and the status of the licenses for the local company as a deal fallout has proven to sour the markets.

As of 3:07 p.m. EST on Monday, Scythian’s share price on the TSX Venture exchange declined 10.55 percent. The company is currently valued at C$16.28 per share.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days

The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less